Duo Venous Stent System
Philips Image Guided Therapy Corporation · Decision date Aug 26, 2026
What did the FDA decide?
FDA records P230021/S004 as a supplement to PMA P230021, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 26, 2026.
FDA approval order statement
changes to the nitinol material and supplier
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P230021/S004
- Regulatory pathway
- PMA supplement
- Product code
- QAN
- Decision code
- OK30
- Decision date
- Aug 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, iliac vein.
- Product code
- QAN
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P230021/S002 · Related supplement
Duo Venous Stent System
P230021/S003 · Related supplement
Duo Venous Stent System
P230021/S004 received
Application receipt date recorded by FDA.
P230021/S004 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P230021. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230021
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Duo Venous Stent SystemP230021/S002 | Philips Image Guided Therapy Corporation | PMA supplement | Nov 18, 2025 | FDA |
Duo Venous Stent SystemP230021/S003 | Philips Image Guided Therapy Corporation | PMA supplement | Feb 12, 2026 | FDA |
Explore the linked device profile
Other records with product code QAN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Abre Venous Self-expanding Stent SystemP200026/S020 | Medtronic Vascular, Inc. | PMA supplement | Oct 30, 2026 | FDA |
Abre Venous Self-Expanding Stent SystemP200026/S019 | Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Venovo Venous Stent SystemP180037/S015 | Bard Peripheral Vascular, Inc. | PMA supplement | Jun 10, 2026 | FDA |
Abre Venous Self-expanding Stent SystemP200026/S018 | Medtronic Vascular, Inc. | PMA supplement | Apr 27, 2026 | FDA |
Zilver Vena Venous Self-Expanding StentP200023/S009 | Cook Ireland, Ltd. | PMA supplement | Apr 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Philips Image Guided Therapy Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 5905 Nathan Ln. N., Plymouth, MN, 55442
Sources and methodology
- Original FDA record: P230021/S004
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




